Bamburgh Capital advised AscellaHealth LLC, a large, fast-growing US-based pharma services company who was looking to expand its capability into Europe.
A period of strategic advisory work considering both organic and inorganic options culminated in the strategic cross-border acquisition of UK-based, CHAPPER Healthcare, a global pharmaceutical distributor and wholesaler. This acquisition supports an international expansion strategy, enhancing the ability to deliver comprehensive solutions for patients with complex, chronic conditions.
CHAPPER Healthcare operates in over 70 countries and co-founded EUROPACCESS to streamline access to European healthcare systems, brings extensive global reach and distribution expertise.
Bamburgh Capital identified and approached the shareholders of CHAPPER Healthcare who were not seeking to sell at the time. The sale provided both AscellaHealth and the shareholders of CHAPPER Healthcare with a thoughtfully structed transaction sharing in the upside opportunity from the combination of capabilities.